William Frietze

Person

Kennett Square, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Salts and processes of preparing a PI3K inhibitor
- Patent number 12,024,522
- Issue date Jul 2, 2024
- Incyte Corporation
- Lei Qiao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of an HPK1 inhibitor
- Patent number 11,787,784
- Issue date Oct 17, 2023
- Incyte Corporation
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid forms of an HPK1 inhibitor
- Patent number 11,066,394
- Issue date Jul 20, 2021
- Incyte Corporation
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amorphous solid form of a BET protein inhibitor
- Patent number 10,858,372
- Issue date Dec 8, 2020
- Incyte Corporation
- Shili Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amorphous solid form of a BET protein inhibitor
- Patent number 10,329,305
- Issue date Jun 25, 2019
- Incyte Corporation
- Shili Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
- Patent number 10,280,157
- Issue date May 7, 2019
- Incyte Corporation
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
- Patent number 9,873,688
- Issue date Jan 23, 2018
- Incyte Holdings Corporation
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
- Patent number 9,321,755
- Issue date Apr 26, 2016
- Incyte Corporation
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethanamine compounds and methods of using the same
- Patent number 9,035,065
- Issue date May 19, 2015
- Astrazeneca AB
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ethanamine compounds and methods of using the same 545
- Patent number 8,013,165
- Issue date Sep 6, 2011
- Astrazeneca AB
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazolo [4,5-d] pyrimidines as CRF antagonists
- Patent number 6,589,958
- Issue date Jul 8, 2003
- Bristol-Myers Squibb Pharma Company
- William Eric Frietze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin re...
- Patent number 6,579,876
- Issue date Jun 17, 2003
- Bristol-Myers Squibb Pharma Company
- Paul Joseph Gilligan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo-pyridines as corticotropin releasing factor antagonists
- Patent number 6,521,636
- Issue date Feb 18, 2003
- Bristol-Myers Squibb Company
- Paul Joseph Gilligan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo[1,5-A]triazine corticotropin releasing fac...
- Patent number 6,509,338
- Issue date Jan 21, 2003
- Bristol-Myers Squibb Company
- Richard Eric Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin re...
- Patent number 6,365,589
- Issue date Apr 2, 2002
- Bristol-Myers Squibb Pharma Company
- Paul Joseph Gilligan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxime ethers as IIb/IIa antagonists
- Patent number 6,348,504
- Issue date Feb 19, 2002
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazolo[4, 5-D]pyrimidines as CRF antagonists
- Patent number 6,294,671
- Issue date Sep 25, 2001
- DuPont Pharmaceuticals Company
- William Eric Frietze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazinones and derivatives thereof
- Patent number 6,218,391
- Issue date Apr 17, 2001
- DuPont Pharmaceuticals Company
- Argyrios Georgios Arvanitis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazinones and triazinones and their derivatives thereof
- Patent number 6,159,980
- Issue date Dec 12, 2000
- DuPont Pharmaceuticals Company
- Argyrios Georgios Arvanitis
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME
- Publication number 20240425506
- Publication date Dec 26, 2024
- INCYTE CORPORATION
- William Frietze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
- Publication number 20230219976
- Publication date Jul 13, 2023
- INCYTE CORPORATION
- Shili Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME
- Publication number 20230121695
- Publication date Apr 20, 2023
- INCYTE CORPORATION
- William Frietze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF AN HPK1 INHIBITOR
- Publication number 20220162195
- Publication date May 26, 2022
- INCYTE CORPORATION
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS AND PROCESSES OF PREPARING A PI3K INHIBITOR
- Publication number 20220024934
- Publication date Jan 27, 2022
- INCYTE CORPORATION
- Lei Qiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
- Publication number 20210079016
- Publication date Mar 18, 2021
- INCYTE CORPORATION
- Shili Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF AN HPK1 INHIBITOR
- Publication number 20210040071
- Publication date Feb 11, 2021
- INCYTE CORPORATION
- Zhongjiang Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF AN LSD1 INHIBITOR
- Publication number 20210032203
- Publication date Feb 4, 2021
- INCYTE CORPORATION
- Yongchun Pan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME
- Publication number 20190337948
- Publication date Nov 7, 2019
- INCYTE CORPORATION
- William Frietze
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
- Publication number 20190300545
- Publication date Oct 3, 2019
- INCYTE CORPORATION
- Shili Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
- Publication number 20180273546
- Publication date Sep 27, 2018
- INCYTE CORPORATION
- Shili Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR
- Publication number 20180244663
- Publication date Aug 30, 2018
- INCYTE CORPORATION
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO
- Publication number 20180099978
- Publication date Apr 12, 2018
- INCYTE CORPORATION
- Jiacheng Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR
- Publication number 20170121347
- Publication date May 4, 2017
- INCYTE CORPORATION
- Shili Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF AN LSD1 INHIBITOR
- Publication number 20170044101
- Publication date Feb 16, 2017
- INCYTE CORPORATION
- Yongchun Pan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS AND PROCESSES OF PREPARING A PI3K INHIBITOR
- Publication number 20160257689
- Publication date Sep 8, 2016
- INCYTE CORPORATION
- Lei Qiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR
- Publication number 20160221996
- Publication date Aug 4, 2016
- INCYTE CORPORATION
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO
- Publication number 20150344497
- Publication date Dec 3, 2015
- INCYTE CORPORATION
- Jiacheng Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR
- Publication number 20150133674
- Publication date May 14, 2015
- INCYTE CORPORATION
- Ming Tao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ETHANAMINE COMPOUNDS AND METHODS OF USING THE SAME
- Publication number 20130137731
- Publication date May 30, 2013
- AstraZeneca AB
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ethanamine Compounds and Methods of Using the Same
- Publication number 20120277272
- Publication date Nov 1, 2012
- AstraZeneca AB
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ethanamine Compounds and Methods of Using the Same
- Publication number 20120115913
- Publication date May 10, 2012
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZA-BICYCLO[2.2.1]HEPTANE COMPOUNDS AND USES THEREOF
- Publication number 20120094995
- Publication date Apr 19, 2012
- AstraZeneca AB
- Jeffrey Scott Albert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ethanamine Compounds and Methods of Using the Same 545
- Publication number 20100179199
- Publication date Jul 15, 2010
- AstraZeneca AB
- Michael Balestra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor M...
- Publication number 20090012127
- Publication date Jan 8, 2009
- AstraZeneca AB
- Thomas R. Simpson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Pyrazole Derivatives And Their Use As Modulators Of Nicotinic...
- Publication number 20080081833
- Publication date Apr 3, 2008
- AstraZeneca AB
- Glen E. Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nicotinic Acetylcholine Receptor Ligands
- Publication number 20070249588
- Publication date Oct 25, 2007
- AstraZeneca AB
- Glen Ernst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nicotinic AcetylcholineReceptor Ligands
- Publication number 20070244097
- Publication date Oct 18, 2007
- AstraZeneca AB
- Glen Ernst
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazo-triazines as corticotropin releasing factor antagonists
- Publication number 20040023965
- Publication date Feb 5, 2004
- Paul Joseph Gilligan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazolo [4,5-d] pyrimidines as CRF antagonists
- Publication number 20030114451
- Publication date Jun 19, 2003
- William Eric Frietze
- C07 - ORGANIC CHEMISTRY

William Frietze

Person

Patents Grantslast 30 patents

Salts and processes of preparing a PI3K inhibitor

Solid forms of an HPK1 inhibitor

Solid forms of an HPK1 inhibitor

Amorphous solid form of a BET protein inhibitor

Amorphous solid form of a BET protein inhibitor

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

Ethanamine compounds and methods of using the same

Ethanamine compounds and methods of using the same 545

Isoxazolo &#x0005B;4,5-d&#x0005D; pyrimidines as CRF antagonists

Imidazo-pyridines, -pyridazines, and -triazines as corticotropin re...

Imidazo-pyridines as corticotropin releasing factor antagonists

Pyrazolo&#x0005B;1,5-A&#x0005D;triazine corticotropin releasing fac...

Imidazo-pyridines, -pyridazines, and -triazines as corticotropin re...

Oxime ethers as IIb/IIa antagonists

Isoxazolo&#x0005B;4, 5-D&#x0005D;pyrimidines as CRF antagonists

Triazinones and derivatives thereof

Pyrazinones and triazinones and their derivatives thereof

Patents Applicationslast 30 patents

SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME

AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR

SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME

SOLID FORMS OF AN HPK1 INHIBITOR

SALTS AND PROCESSES OF PREPARING A PI3K INHIBITOR

AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR

SOLID FORMS OF AN HPK1 INHIBITOR

SALTS OF AN LSD1 INHIBITOR

SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME

AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR

AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR

PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO

AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR

SALTS OF AN LSD1 INHIBITOR

SALTS AND PROCESSES OF PREPARING A PI3K INHIBITOR

PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

PROCESSES OF PREPARING A JAK1 INHIBITOR AND NEW FORMS THERETO

PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR

ETHANAMINE COMPOUNDS AND METHODS OF USING THE SAME

Ethanamine Compounds and Methods of Using the Same

Ethanamine Compounds and Methods of Using the Same

2-AZA-BICYCLO[2.2.1]HEPTANE COMPOUNDS AND USES THEREOF

Ethanamine Compounds and Methods of Using the Same 545

Thiophene-2-Carboxamide Derivatives as Alpha 7 Nicotinic Receptor M...

Novel Pyrazole Derivatives And Their Use As Modulators Of Nicotinic...

Nicotinic Acetylcholine Receptor Ligands

Nicotinic AcetylcholineReceptor Ligands

Imidazo-triazines as corticotropin releasing factor antagonists

Isoxazolo [4,5-d] pyrimidines as CRF antagonists

Isoxazolo [4,5-d] pyrimidines as CRF antagonists

Pyrazolo[1,5-A]triazine corticotropin releasing fac...

Isoxazolo[4, 5-D]pyrimidines as CRF antagonists